Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Association of Calcitriol Supplementation with Reduced COVID-19 Mortality in Patients with Chronic Kidney Disease: A Population-based Study

Oristrell et al., Biomedicines, doi:10.3390/biomedicines9050509 (date from preprint)
Apr 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
0 0.5 1 1.5 2+ Mortality 43% Improvement Relative Risk Severe case 43% Case 22% Vitamin D for COVID-19  Oristrell et al.  Prophylaxis Is prophylaxis with vitamin D beneficial for COVID-19? Retrospective 5,703 patients in Spain Lower mortality (p=0.001) and severe cases (p=0.00082) c19early.org Oristrell et al., Biomedicines, April 2021 Favors vitamin D Favors control
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 120 studies, recognized in 9 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,200+ studies for 70+ treatments. c19early.org
Retrospective study of calcitriol supplementation with chronic kidney disease patients in Catalonia showing lower cases, severe cases, and mortality with supplementation. A dose-response relationship was found for severe cases and mortality.
This is the 29th of 120 COVID-19 controlled studies for vitamin D, which collectively show efficacy with p<0.0000000001 (1 in 268 sextillion).
29 studies are RCTs, which show efficacy with p=0.000005.
risk of death, 43.0% lower, HR 0.57, p = 0.001, treatment 2,296, control 3,407, multivariate, patients with CKD stages 4-5.
risk of severe case, 43.0% lower, HR 0.57, p < 0.001, treatment 2,296, control 3,407, multivariate, patients with CKD stages 4-5.
risk of case, 22.0% lower, HR 0.78, p = 0.01, treatment 163 of 2,296 (7.1%), control 326 of 3,407 (9.6%), NNT 40, multivariate, patients with CKD stages 4-5.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Oristrell et al., 6 Apr 2021, retrospective, Spain, peer-reviewed, 10 authors, dosage calcitriol 0.3μg daily, mean daily dose.
This PaperVitamin DAll
Association of Calcitriol Supplementation with Reduced COVID-19 Mortality in Patients with Chronic Kidney Disease: A Population-Based Study
Joaquim Oristrell, Joan Carles Oliva, Isaac Subirana, Enrique Casado, Didier Domínguez, Andrea Toloba, Patricia Aguilera, Joan Esplugues, Pilar Fafián, Maria Grau
Biomedicines, doi:10.3390/biomedicines9050509
Treatment with calcitriol, the hormonal form of vitamin D, has shown beneficial effects in experimental models of acute lung injury. In this study, we aimed to analyze the associations between calcitriol supplementation and the risk of SARS-CoV2 infection or COVID-19 mortality. Individuals ≥18 years old living in Catalonia and supplemented with calcitriol from April 2019 to February 2020 were compared with propensity score matched controls. Outcome variables were SARS-CoV2 infection, severe COVID-19 and COVID-19 mortality. Associations between calcitriol supplementation and outcome variables were analyzed using multivariable Cox proportional regression. A total of 8076 patients were identified as being on calcitriol treatment. Advanced chronic kidney disease and hypoparathyroidism were the most frequent reasons for calcitriol supplementation in our population. Calcitriol use was associated with reduced risk of SARS-CoV2 infection (HR 0.78 [CI 95% 0.64-0.94], p = 0.010), reduced risk of severe COVID-19 and reduced COVID-19 mortality (HR 0.57 (CI 95% 0.41-0.80), p = 0.001) in patients with advanced chronic kidney disease. In addition, an inverse association between mean daily calcitriol dose and COVID-19 severity or mortality was observed in treated patients, independently of renal function. Our findings point out that patients with advanced chronic kidney disease could benefit from calcitriol supplementation during the COVID-19 pandemic.
References
Annweiler, Corvaisier, Gautier, Dubée, Legrand et al., Vitamin D Supplementation Associated to Better Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Quasi-Experimental Study, Nutrition, doi:10.3390/nu12113377
Bergman, Lindh, Björkhem-Bergman, Lindh, Vitamin D and respiratory tract infections: A systematic review and me-ta-analysis of randomized controlled trials, PLoS ONE, doi:10.1371/journal.pone.0065835
Castillo, Entrenas Costa, Vaquero Barrios, Díaz, Miranda et al., Effect of calcifediol treatment and best available tehrapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study, J. Steroid Biochem. Mol. Biol, doi:10.1016/j.jsbmb.2020.105751
Cereda, Bogliolo, Lobascio, Barichella, Zecchinelli et al., Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy, Italy, Nutrition
Dancer, Parekh, Lax, D'souza, Zheng et al., Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS), Thorax, doi:10.1136/thoraxjnl-2014-206680
Greiller, Martineau, Modulation of the Immune Response to Respiratory Viruses by Vitamin, D. Nutrients, doi:10.3390/nu7064240
Hansdottir, Monick, Lovan, Powers, Gerke et al., Vitamin D decreases respiratory syncytial virus induction of NF-kB chemokines and cytokines in airway epithelium while maintaining the antiviral state, J. Immunol, doi:10.4049/jimmunol.0902840
Kassambara, Kosinski, Biecek, Biecek, Fabian, Survminer: Drawing Survival Curves Using 'ggplot2
Kdigo Guidelines, CKD-Mineral and Bone Disorder (CKD-MBD
Kong, Zhu, Shi, Liu, Chen et al., VDR Attenuates Acute Lung Injury by Blocking Ang-2-Tie-2 Pathway and Renin-Angiotensin System, Mol. Endocrinol, doi:10.1210/me.2013-1146
Kuba, Ima, Rao, Gao, Guo et al., A crucial role of angiotensin convertint enzyme 2 (ACE2) in SARS coronavirus-induced lung injury, Nat. Med, doi:10.1038/nm1267
Letko, Marzi, Munster, Functional assessment of cell entry and receptor usage for SARS-CoV2 and other lineage B betacoronaviruses, Nat. Microbiol, doi:10.1038/s41564-020-0688-y
Levey, Stevens, Schmid, Zhang, Castro et al., Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate, Ann. Intern. Med, doi:10.7326/0003-4819-150-9-200905050-00006
Levin, Bakris, Molitch, Smulders, Tian et al., Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease, Kidney Int, doi:10.1038/sj.ki.5002009
Levin, Bilous, Coresh, Chapter 1: Definition and classification of CKD, Kidney Int. Suppl, doi:10.1038/kisup.2012.64
Machado, Aissa, Ribeiro, Antunes, Vitamin D supplementation alters the expression of genes associated with hypertension and did not induce DNA damage in rats, J. Toxicol. Environ. Health Part A, doi:10.1080/15287394.2019.1592044
Martineau, Jolliffe, Hooper, Greenberg, Aloia et al., Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data, BMJ, doi:10.1136/bmj.i6583
Murai, Fernandes, Sales, Pinto, Goessler et al., Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19, JAMA, doi:10.1001/jama.2020.26848
Rastogi, Bhansali, Khare, Suri, Yaddanapudi et al., Short term, high-dose vitamin D supplementation for COVID-19 disease: A randomised, placebo-controlled, study (SHADE study), Postgrad. Med. J, doi:10.1136/postgradmedj-2020-139065
Riera, Anguiano, Clotet, Roca-Ho, Rebull et al., Paricalcitol modulates ACE2 shedding and renal AD-AM17 in NOD mica beyond proteinuria, Am. J. Physiol. Renal. Physiol, doi:10.1152/ajprenal.00082.2015
Santos, Ferreira, Silva, Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis, Exp. Physiol, doi:10.1113/expphysiol.2008.042002
Santos, Oliveira Sampaio, Alzamora, Motta-Santos, Alenina et al., The ACE2/Angiotensin-(1-7)/Mas axis of the renin-angiotensin System: Focus on angiotensin-(1-7), Physiol. Rev, doi:10.1152/physrev.00023.2016
Sekhon, Multivariate and propensity score matching software with automated balance Ootimization: The matching pack-age for R, J. Statist. Soft, doi:10.18637/jss.v042.i07
Sodhi, Wohlford-Lenane, Yamaguchi, Prindle, Fulton et al., Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration, Am. J. Physiol. Lung Cell. Mol. Physiol, doi:10.1152/ajplung.00498.2016
Swami, Krishnan, Moreno, Bhattacharyya, Peehl et al., Calcitriol and genistein actions to inhibit the prostaglandin pathway: Potential com-bination therapy to treat prostate cancer, J. Nutr, doi:10.1093/jn/137.1.205S
Teymoori-Rad, Marashi, Vitamin D and Covid-19: From potential therapeutic effects to unanswered questions, Rev. Med. Virol, doi:10.1002/rmv.2159
Therneau, A Package for Survival Analysis in R. R Package Version
Williamson, Walker, Bhaskaran, Bacon, Bates et al., Factors associated with COVID-19-related death using OpenSAFELY, Nature, doi:10.1038/s41586-020-2521-4
Xu, Yang, Chen, Luo, Zhang et al., Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system, Mol. Med. Rep, doi:10.3892/mmr.2017.7546
Yang, Zheng, Gou, Pu, Chen et al., Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis, Int. J. Infect. Dis, doi:10.1016/j.ijid.2020.03.017
Yoshida, Bohn, Package 'tableone' for R
{ 'indexed': {'date-parts': [[2024, 3, 4]], 'date-time': '2024-03-04T02:39:15Z', 'timestamp': 1709519955276}, 'reference-count': 31, 'publisher': 'MDPI AG', 'issue': '5', 'license': [ { 'start': { 'date-parts': [[2021, 5, 5]], 'date-time': '2021-05-05T00:00:00Z', 'timestamp': 1620172800000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by/4.0/'}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'abstract': '<jats:p>Treatment with calcitriol, the hormonal form of vitamin D, has shown beneficial ' 'effects in experimental models of acute lung injury. In this study, we aimed to analyze the ' 'associations between calcitriol supplementation and the risk of SARS-CoV2 infection or ' 'COVID-19 mortality. Individuals ≥18 years old living in Catalonia and supplemented with ' 'calcitriol from April 2019 to February 2020 were compared with propensity score matched ' 'controls. Outcome variables were SARS-CoV2 infection, severe COVID-19 and COVID-19 mortality. ' 'Associations between calcitriol supplementation and outcome variables were analyzed using ' 'multivariable Cox proportional regression. A total of 8076 patients were identified as being ' 'on calcitriol treatment. Advanced chronic kidney disease and hypoparathyroidism were the most ' 'frequent reasons for calcitriol supplementation in our population. Calcitriol use was ' 'associated with reduced risk of SARS-CoV2 infection (HR 0.78 [CI 95% 0.64–0.94], p = 0.010), ' 'reduced risk of severe COVID-19 and reduced COVID-19 mortality (HR 0.57 (CI 95% 0.41–0.80), p ' '= 0.001) in patients with advanced chronic kidney disease. In addition, an inverse ' 'association between mean daily calcitriol dose and COVID-19 severity or mortality was ' 'observed in treated patients, independently of renal function. Our findings point out that ' 'patients with advanced chronic kidney disease could benefit from calcitriol supplementation ' 'during the COVID-19 pandemic.</jats:p>', 'DOI': '10.3390/biomedicines9050509', 'type': 'journal-article', 'created': {'date-parts': [[2021, 5, 5]], 'date-time': '2021-05-05T15:06:01Z', 'timestamp': 1620227161000}, 'page': '509', 'source': 'Crossref', 'is-referenced-by-count': 15, 'title': 'Association of Calcitriol Supplementation with Reduced COVID-19 Mortality in Patients with ' 'Chronic Kidney Disease: A Population-Based Study', 'prefix': '10.3390', 'volume': '9', 'author': [ { 'ORCID': 'http://orcid.org/0000-0003-1486-3192', 'authenticated-orcid': False, 'given': 'Joaquim', 'family': 'Oristrell', 'sequence': 'first', 'affiliation': []}, {'given': 'Joan Carles', 'family': 'Oliva', 'sequence': 'additional', 'affiliation': []}, {'given': 'Isaac', 'family': 'Subirana', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-8839-6430', 'authenticated-orcid': False, 'given': 'Enrique', 'family': 'Casado', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-0258-6194', 'authenticated-orcid': False, 'given': 'Didier', 'family': 'Domínguez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrea', 'family': 'Toloba', 'sequence': 'additional', 'affiliation': []}, {'given': 'Patricia', 'family': 'Aguilera', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joan', 'family': 'Esplugues', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pilar', 'family': 'Fafián', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-2807-8136', 'authenticated-orcid': False, 'given': 'Maria', 'family': 'Grau', 'sequence': 'additional', 'affiliation': []}], 'member': '1968', 'published-online': {'date-parts': [[2021, 5, 5]]}, 'reference': [ {'key': 'ref1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ijid.2020.03.017'}, {'key': 'ref2', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41564-020-0688-y'}, {'key': 'ref3', 'doi-asserted-by': 'publisher', 'DOI': '10.1113/expphysiol.2008.042002'}, {'key': 'ref4', 'doi-asserted-by': 'publisher', 'DOI': '10.1152/physrev.00023.2016'}, {'key': 'ref5', 'doi-asserted-by': 'publisher', 'DOI': '10.1152/ajplung.00498.2016'}, {'key': 'ref6', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/nm1267'}, {'key': 'ref7', 'doi-asserted-by': 'publisher', 'DOI': '10.1152/ajprenal.00082.2015'}, {'key': 'ref8', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/nu7064240'}, {'key': 'ref9', 'doi-asserted-by': 'publisher', 'DOI': '10.1210/me.2013-1146'}, {'key': 'ref10', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/thoraxjnl-2014-206680'}, {'key': 'ref11', 'doi-asserted-by': 'publisher', 'DOI': '10.3892/mmr.2017.7546'}, {'key': 'ref12', 'doi-asserted-by': 'publisher', 'DOI': '10.1080/15287394.2019.1592044'}, {'key': 'ref13', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/rmv.2159'}, {'key': 'ref14', 'doi-asserted-by': 'publisher', 'DOI': '10.18637/jss.v042.i07'}, {'key': 'ref15', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41586-020-2521-4'}, { 'key': 'ref16', 'doi-asserted-by': 'publisher', 'DOI': '10.7326/0003-4819-150-9-200905050-00006'}, { 'key': 'ref17', 'unstructured': 'Package ‘tableone’ for ' 'Rhttps://cran.r-project.org/web/packages/tableone/tableone.pdf'}, {'key': 'ref18', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/kisup.2012.64'}, { 'key': 'ref19', 'unstructured': 'A Package for Survival Analysis in R. R Package Version ' '3.2-7https://CRAN.R-project.org/package=survival'}, { 'key': 'ref20', 'unstructured': 'Survminer: Drawing Survival Curves Using ' '‘ggplot2’https://CRAN.R-project.org/package=survminer'}, {'key': 'ref21', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0065835'}, {'key': 'ref22', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj.i6583'}, {'key': 'ref23', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.nut.2020.111055'}, {'key': 'ref24', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/nu12113377'}, {'key': 'ref25', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jsbmb.2020.105751'}, {'key': 'ref26', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/postgradmedj-2020-139065'}, {'key': 'ref27', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jama.2020.26848'}, {'key': 'ref28', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/sj.ki.5002009'}, { 'key': 'ref29', 'unstructured': 'CKD-Mineral and Bone Disorder ' '(CKD-MBD)https://kdigo.org/guidelines/ckd-mbd/'}, {'key': 'ref30', 'doi-asserted-by': 'publisher', 'DOI': '10.4049/jimmunol.0902840'}, {'key': 'ref31', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/jn/137.1.205S'}], 'container-title': 'Biomedicines', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://www.mdpi.com/2227-9059/9/5/509/pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 5, 5]], 'date-time': '2021-05-05T15:29:04Z', 'timestamp': 1620228544000}, 'score': 1, 'resource': {'primary': {'URL': 'https://www.mdpi.com/2227-9059/9/5/509'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 5, 5]]}, 'references-count': 31, 'journal-issue': {'issue': '5', 'published-online': {'date-parts': [[2021, 5]]}}, 'alternative-id': ['biomedicines9050509'], 'URL': 'http://dx.doi.org/10.3390/biomedicines9050509', 'relation': { 'has-preprint': [ { 'id-type': 'doi', 'id': '10.20944/preprints202104.0173.v1', 'asserted-by': 'object'}]}, 'ISSN': ['2227-9059'], 'subject': ['General Biochemistry, Genetics and Molecular Biology', 'Medicine (miscellaneous)'], 'container-title-short': 'Biomedicines', 'published': {'date-parts': [[2021, 5, 5]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit